Atlas Trials

Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)

Clinical trial NCT07521670 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07521670
Sponsor
National Cancer Centre, Singapore
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Adenoid Cystic CarcinomaAdenoid Cystic Carcinoma MetastaticPapillary Thyroid Carcinoma
Start date
2026-11-01
Primary completion
2028-10-31
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.